Characterization of Equilibrative Nucleoside Transport of the Pancreatic Cancer Cell Line: Panc-1
{{output}}
Objectives: Gemcitabine, a first-line chemotherapeutic nucleoside analog drug (NAD) for pancreatic cancer, faces limitations due to drug resistance. Characterizing pancreatic cancer cells' transport characteristics may help ident... ...
